Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial; C-SMART Study.

NCT04534725 is registered in ClinicalTrials.gov with Peter MacCallum Cancer Centre, Australia as lead sponsor.

NCT NCT04534725
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04534725 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial; C-SMART Study.
Lead sponsor
Peter MacCallum Cancer Centre, Australia
Phase
Phase 3
Overall status
Completed
Start date
December 17, 2020
Completion date
April 19, 2023
Enrollment
441 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, covid19, respiratory viral infection